Department of Neurosurgery, Yale University School of Medicine, New Haven, CT.
Spine (Phila Pa 1976). 2021 Jun 15;46(12):828-835. doi: 10.1097/BRS.0000000000003907.
Retrospective cohort study.
The aim of this study was to investigate differences in 30- and 90-day readmissions for spine metastases treated with decompression and/or fusion spine surgery in a nationwide readmission database.
Patients with metastases to the spine represent a particularly vulnerable patient group that may encounter frequent readmissions. However, the 30- and 90-day rates for readmission following surgery for spine metastases have not been well described.
The Nationwide Readmission Database years 2013 to 2015 was queried. Patients were grouped by no readmission (non-R), readmission within 30 days (30-R), and readmission within 31 to 90 days (90-R). Weighted multivariate analysis assessed impact of treatment approach and clinical factors associated with 30- and 90-day readmissions.
There were a total of 4423 patients with a diagnosis of spine metastases identified who underwent spine surgery, of which 1657 (37.5%) encountered either a 30-or 90-day unplanned readmission (30-R: n = 1068 [24-.1%]; 90-R: n = 589 [13.3%]; non-R: n = 2766). The most prevalent inpatient complications observed were postoperative infection (30-R: 16.3%, 90-R: 14.3%, non-R: 11.5%), acute post-hemorrhagic anemia (30-R: 13.4%, 90-R: 14.2%, non-R: 14.5%), and genitourinary complication (30-R: 5.7%, 90-R: 2.9%, non-R: 6.2%). The most prevalent 30-day and 90-day reasons for admission were sepsis (30-R: 10.2%, 90-R: 10.8%), postoperative infection (30-R: 13.7%, 90-R: 6.5%), and genitourinary complication (30-R: 3.9%, 90-R: 4.1%). On multivariate regression analysis, surgery type, age, hypertension, and renal failure were independently associated with 30-day readmission; rheumatoid arthritis/collagen vascular diseases, and coagulopathy were independently associated with 90-day readmission.
In this study, we demonstrate several patient-level factors independently associated with unplanned hospital readmissions after surgical treatment intervention for spine metastases. Furthermore, we find that the most common reasons for readmission are sepsis, postoperative infection, and genitourinary complications.Level of Evidence: 3.
回顾性队列研究。
本研究旨在调查在全国性再入院数据库中,接受减压和/或融合脊柱手术治疗的脊柱转移瘤患者的 30 天和 90 天再入院差异。
脊柱转移瘤患者代表了一个特别脆弱的患者群体,他们可能会经常需要再入院。然而,脊柱转移瘤手术后 30 天和 90 天的再入院率尚未得到很好的描述。
查询了全国再入院数据库 2013 年至 2015 年的数据。根据是否再入院(非再入院[NR]、30 天内再入院[30-R]和 31-90 天内再入院[90-R]将患者分组。加权多变量分析评估了治疗方法和与 30 天和 90 天再入院相关的临床因素的影响。
共有 4423 例脊柱转移瘤患者接受了脊柱手术,其中 1657 例(37.5%)在 30 天或 90 天内发生了非计划再入院(30-R:n=1068[24.1%];90-R:n=589[13.3%];NR:n=2766)。观察到的最常见的住院并发症是术后感染(30-R:16.3%,90-R:14.3%,NR:11.5%)、急性出血后贫血(30-R:13.4%,90-R:14.2%,NR:14.5%)和泌尿生殖系统并发症(30-R:5.7%,90-R:2.9%,NR:6.2%)。30 天和 90 天最常见的入院原因是败血症(30-R:10.2%,90-R:10.8%)、术后感染(30-R:13.7%,90-R:6.5%)和泌尿生殖系统并发症(30-R:3.9%,90-R:4.1%)。多变量回归分析显示,手术类型、年龄、高血压和肾衰竭与 30 天再入院独立相关;类风湿关节炎/胶原血管疾病和凝血障碍与 90 天再入院独立相关。
在这项研究中,我们证明了几个与脊柱转移瘤患者手术后计划外住院再入院相关的患者水平因素。此外,我们发现再入院的最常见原因是败血症、术后感染和泌尿生殖系统并发症。
3 级。